secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tenaya Therapeutics, Inc. (TNYA)
CIK:        0001858848
Form:       8-K
Filed at:   2024-02-08T23:59:59+00:00
Accession:  0001193125-24-027611
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tenaya Therapeutics prices $50M public offering of 8.9M shares and pre-funded warrants at $4.50/share
--------------------------------------------------------------------------------

- Gross proceeds expected ~$50M from 8,888,890 common shares at $4.50 and 2,222,271 pre-funded warrants at $4.499.
- Offering includes participation from The Column Group, RA Capital, BlackRock, and other investors.
- Expected to close February 12, 2024; Leerink Partners and TD Cowen are joint book-running managers.
- Pre-funded warrants exercisable at $0.001 per share immediately until fully exercised.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1858848/000119312524027611/0001193125-24-027611-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1858848/000119312524027611/d761271d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-027611

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer